WHO: Loneliness can make you very sick, cost billions in health care
GENEVA (dpa)One in six people worldwide is affected by loneliness, which, along with social isolation, can lead to physical illness, contributing to 871,000 deaths worldwide annually, a World Health Organization (WHO) commission has said.Loneliness increases the risk of strokes, heart attacks, diabetes, depression, anxiety and suicide, the WHO said.Lonely teenagers are 22% more likely to achieve lower grades than their peers, while lonely adults face greater challenges in finding or keeping a job.The impact is not only individual but also societal, with billions in costs to healthcare systems and losses in employment.The commission's co-chair, Vivek Murthy, defines loneliness as "a painful, subjective feeling that many of us experience when the relationships that we need do not match the relationships that we have. And social isolation, by contrast, is an objective state of having few relationships or interactions."
The Role of Digital Technologies One in three older people and one in four adolescents are estimated to be socially isolated, according to the report. Causes include illness, poor education, low income, a lack of opportunities for social interaction, living alone, and the use ofdigital technologies.Murthy noted that humans have communicated for millennia not only through words but also through facial expressions, body language, tone of voice and silence.
These forms of communication are lost when people rely solely on mobile phones and social media.
Sweden StrategyThe WHO highlighted Sweden as a positive example. The country has implemented a national strategy against loneliness, as reported by Swedish Social Minister Jakob Forssmed.Sweden recognises that loneliness is not just an individual problem but one that affects society as a whole. Efforts are being made to foster social connections in places like shops, restaurants, neighbourhoods and clubs.Soon, all children and teenagers in Sweden will receive prepaid cards that can only be used to book group leisure activities.Sweden plans to ban mobile phones in public schools, Forssmed said. Studies have shown that this increases social interaction and reduces cyberbullying. Children and teenagers sleep better and find it easier to put their phones aside during their free time.Forssmed added that children are often frustrated when their parents are constantly distracted by their phones.
Phone-free Times While digital technologies have their benefits, such as enabling video calls that were previously impossible, the commission emphasised the importance of creating spaces in life where people can interact face-to-face without technological distractions.Murthy said "having places and spaces in our life where we can interact face to face with other people without the distraction of technology is very important."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
10 hours ago
- Zawya
Hexavalent in Senegal: A step forward for immunization coverage and child health
On the morning of July 1, 2025, Aissatou, a young mother from Diamniadio, arrived early at the health center, her two-month-old baby snuggled against her. She hadn't come for a routine consultation—today, her child was receiving the new hexavalent vaccine. 'Before, I was afraid of multiple injections for my baby. Today, the health workers explained to me that a single dose protects against six serious diseases. It's reassuring to know that he'll suffer less while being better protected,' confides Aissatou, gazing at her sleeping son. Like her child, 640,000 infants are targeted this year by the new vaccination schedule. Thanks to the introduction of the hexavalent vaccine, they will be protected against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenzae type B (Hib), and poliomyelitis—all in a single shot. Behind this apparent simplification lies a long process of preparation. The Expanded Programme on Immunization (EPI), with technical and financial support from partners such as Gavi and the World Health Organization (WHO), led an ambitious transition. WHO in particular trained nearly 6,000 health workers, ensured rigorous cold chain management (the vaccine must be kept between +2°C and +8°C), and deployed digital real-time monitoring tools. 'Hexavalent represents a qualitative leap for us vaccinators. A single injection means faster vaccination, less crying, and above all, greater protection,' explains Aminata, a vaccinator in Diamniadio. 1.6 million doses have been positioned across the country's 14 regions. The aim is to achieve at least 90% vaccination coverage by the end of the year. And the expected benefits are considerable: according to Ministry of Health projections, the introduction of this vaccine could halve hospitalizations for the targeted diseases by 2030. For Dr. Badiane, coordinator of the national EPI, this reform marks a turning point: 'It's not just a change of vaccine—it's a new paradigm. We're simplifying the schedule, strengthening immunity, and gaining in effectiveness in the field. WHO's support has been decisive at every stage.' Beyond the numbers and logistics, it's families like Aissatou's who are feeling the change in concrete terms: less stress at each vaccination appointment, a better understanding of health issues, and above all, renewed confidence in the healthcare system. Dr. Jean-Marie Vianny Yameogo, WHO Representative in Senegal, sees this transition as an illustration of health equity: 'Introducing the hexavalent vaccine means offering every Senegalese child the same chance to grow up in good health. It's a concrete commitment to reducing inequalities and building a fairer future for all.' As she leaves the health center, vaccination booklet in hand, Aissatou takes a moment to smile. 'I'll be back for the other doses. My child deserves the best possible protection.' An individual decision—but a collective step towards a healthier future. Distributed by APO Group on behalf of World Health Organization (WHO) - Senegal.
Zawya
17 hours ago
- Zawya
United Nations (UN) Leaders engage World Health Organization (WHO) Botswana to strengthen coordination and multilateral collaboration
In an expression of strengthened partnership and renewed commitment to multilateralism, the WHO Botswana Country Office recently hosted two high-level courtesy calls from newly appointed UN leaders, Ms. Wenyan Yang, the UN Resident Coordinator in Botswana, and Ms. Nthisana Motsete-Phillips, Botswana's incoming Permanent Representative to Switzerland and the United Nations in Geneva. Ms. Wenyan Yang's visit formed part of her introductory engagements with UN agencies in Botswana. She was warmly welcomed by the WHO team and WHO Representative Dr. Fabian Ndenzako. During the meeting, Ms. Yang shared her vision of fostering collaboration, innovation, and collective impact within the UN Country Team, stressing the need for creative and integrated approaches amid global financial constraints. 'We must find new and more effective ways of working together leveraging our collective strengths to deliver real, measurable change for the people of Botswana,' said Ms. Yang. With over 30 years of experience in the UN system, she reaffirmed her commitment to working closely with agencies to deliver results that positively impact the lives of Batswana. Dr. Ndenzako briefed her on WHO's key areas of support, highlighting national health priorities such as the transition of primary healthcare to local government, the rollout of national health insurance, and the strengthening of health sector coordination. He acknowledged the country's achievements in areas like HIV control and maternal health, while noting ongoing challenges in achieving universal health coverage and meeting the Sustainable Development Goals (SDGs). Welcoming Ms. Yang's leadership, Dr. Ndenzako emphasized her crucial role in advocating for stronger coordination within the UN system and aligning support to accelerate Botswana's national development agenda. Meanwhile, WHO Botswana also engaged with Ms. Nthisana Motsete-Phillips as she prepares to assume office in Geneva. Her visit focused on strengthening the relationship between Geneva-based multilateral platforms and in-country implementation. Dr. Ndenzako lauded Botswana's active voice within the Africa Group and other global health fora and highlighted the critical role of WHO Botswana's Geneva liaison in bridging global and national priorities. He also drew attention to ongoing global shifts, including shrinking donor budgets, institutional restructuring, and declining development financing, all of which demand strategic engagement by countries like Botswana in global health diplomacy. Ms. Motsete-Phillips expressed her intention to serve as a practical and results-oriented bridge between Geneva and national stakeholders. 'We must ensure that what is discussed and committed to in Geneva translates into impact on the ground. It is my responsibility to help make that connection real for Botswana,' she said. With a background in the private sector and several years of experience in Switzerland, she pledged to help translate global commitments into tangible, on-the-ground outcomes. She underscored the need for closer coordination between Botswana's Geneva mission and local UN country teams to ensure coherent policy implementation. She also raised concerns about inefficiencies within public institutions and emphasized the importance of accountability and strong follow-through, particularly in managing partnerships and national programmes. Noting the complexity of agendas such as universal health coverage, she called for more realistic and transparent communication strategies. Additionally, she expressed interest in strengthening collaboration with institutions such as the Botswana Vaccine Institute (BVI). Challenging the prevailing classification of Botswana as a middle-income country, Ms. Motsete-Phillips warned that this status often excludes the country from much-needed support. She called for a renewed and nuanced narrative that reflects Botswana's current realities and development needs. Both visits underscored a shared commitment to deepening collaboration, improving coordination at all levels, and ensuring Botswana's continued active role in shaping and implementing global health and development priorities. Distributed by APO Group on behalf of World Health Organization (WHO), Botswana.
Zawya
17 hours ago
- Zawya
Sierra Leone bolters mpox response: World Health Organization (WHO) leads groundbreaking genomic surveillance and bioinformatics training
In a strategic initiative aimed at enhancing mpox outbreak response and genomic surveillance capacity, the Central Public Health Reference Laboratory (CPHRL) in Freetown hosted the mpox Genomics and Bioinformatics training workshop from 23rd – 27th June 2025. The event was organized under the theme: 'Strengthening Genomic Surveillance Capacity for mpox Response in Sierra Leone,' with technical and financial support from the World Health Organization (WHO AFRO and WHO Sierra Leone). The training program targeted 15 participants, including laboratory scientists, public health professionals, and epidemiologists from across Sierra Leone. Despite reporting over 4,400 confirmed cases of mpox as of 27th June 2025, Sierra Leone has performed genomic characterization on only approximately 2.5% of these cases (108 sequences), representing a significant limitation in understanding viral evolution and informing targeted public health interventions. Currently, these genomic data are deposited in international repositories such as Pathoplexus, GISAID, and NCBI Virus; however, the disparity between outbreak detection and genomic data generation hampers real-time surveillance efforts. The Ministry of Health and Sanitation (MoHS) and the Sierra Leone National Public Health Agency (SLNPHA) of Sierra Leone have prioritized strengthening genomic surveillance to enable rapid outbreak detection, track viral transmission, and inform policy decisions. Allan Campbell, Laboratory Lead at CPHRL, emphasized the significance of this training, stating, 'This marks a pivotal moment in Sierra Leone's national response to mpox. The initiative addresses the substantial bioinformatics capacity gap and establishes a foundation for sustainable genomic surveillance that can directly inform public health actions.' The workshop aligns with the objectives outlined in the WHO African Region (AFRO) Joint Continental mpox Response Plan 2.0, focusing on intensification, integration, and establishing a sustainable legacy in genomic epidemiology. The week-long workshop employed a multidisciplinary, hands-on approach combining didactic instruction, practical exercises, and group data analysis. The curriculum included: Day 1: Introduction to genomic surveillance principles, sequencing technologies, and foundational bioinformatics tools such as Linux and Conda environments. Day 2: Emphasis on sequencing data quality control (FastQC, MultiQC), read trimming (Fastp, Hostile), and genome assembly techniques utilizing reference-based (BWA, Cutadapt) and de novo (SPAdes) approaches. Day 3: Variant detection and analysis (SAMtools, FreeBayes, Snippy), consensus sequence generation (Bcftools), and genome annotation (SnpEff, VEP). Day 4: Phylogenetic analysis, clade classification (Nextclade, Nextstrain), and visualization using platforms such as GISAID, Pathoplexus, NCBI Virus, Microreact, iTOL, and Galaxy. Day 5: Integration of all components through a case study simulating mpox outbreak response, culminating in data interpretation and strategic planning. Walter Oguta, WHO AFRO EPI Analytics Specialist and the Lead Bioinformatics Trainer, underscored the practical value of the training, stating, 'Translating genomic data into actionable public health strategies is the ultimate goal. Our aim was to equip participants with both technical proficiency and confidence to utilize these tools effectively.' Doris Harding, Laboratory Pillar Lead at the SLNPHA, highlighted the broader implications: 'Strengthening our capacity for genomic surveillance is no longer optional—it is essential. This initiative empowers our scientists to respond more effectively to mpox and other emerging pathogens.' Similarly, Jonathan Greene, WHO Sierra Leone Laboratory Lead, articulated the importance of workforce development, asserting, 'Building a skilled, locally capable workforce is central to WHO's strategy for resilient health systems. The use of genomics is transforming outbreak intelligence, enabling a shift from reactive to proactive responses.' Dr. Ameh George, WHO Representative in Sierra Leone, emphasized the strategic importance of institutionalizing genomic surveillance: 'Genomics is redefining outbreak science. Sierra Leone must lead in generating and utilizing genomic data to inform policy and strengthen global health security. WHO remains committed to supporting this transformation.' Participants and stakeholders concurred that this training initiative constitutes a long-term investment in Sierra Leone's epidemic preparedness, response and resilience. By decentralizing sequencing capabilities and integrating genomic data into national decision-making processes, the program aspires to support regional efforts for early detection and rapid response to outbreaks. The workshop concluded with the issuance of certificates of completion and a networking session aimed at fostering collaboration and innovation in public health genomics. As Sierra Leone advances its surveillance infrastructure, the overarching goal remains to elevate genomic data from an underutilized resource to a central element of outbreak response and epidemic intelligence, thereby strengthening national and regional health security. Distributed by APO Group on behalf of World Health Organization - Sierra Leone.
